Manzano-Robleda MC, Ornelas-Arroyo S, Toapanta-Yancapaxi L, Motola-Kuba M, Aguilar-Olivos NE, Chávez-Tapia NC, Uribe-Esquivel M

Language: Spanish
References: 7
Page: 43-45
PDF size: 166.94 Kb.

ABSTRACT

Background. The prevalence of hepatic hemangiomas range between 5 and 20% in the general population with a female: male ratio of 6:1. Most of hepatic hemangiomas are asymptomatic. Giant hemangioma is defined by a size ≥ 4 cm, when giant hemangioma is present up to 79% of patients presented abdominal pain. Nowadays, the most accurate method for diagnosis is de image for magnetic resonance with a sensitivity and specificity of 95 and 100% respectively. Aim. Describe the clinical and radiological characteristics of giant hemangiomas clinic cases. Material and methods: All patients with giant hemangioma diagnosis during January 2012 to January 2013 period were included. Results. Three patients with giant hemangioma diagnosis were included, two women and one man, with an age between 30 to 58 years old. Most patients were asymptomatic, but only one presented abdominal pain related to hemangioma size. None of them present with biochemical alteration. All patients were diagnosed by computerized tomography and magnetic resonance imaging. The clinical course of patient one and two has been favorable and will be monitored with annual image studies. The patient number three undergo progressive symptoms due to abdominal pain and multiple giant hemangiomas; assessment has been sent to the surgical service. Conclusion. The hepatic hemangiomas described in this work match with the characteristics described in the literature, being mostly asymptomatic, of a variable size, and most frequent in women. Surgical management is indicated only in giant size tumors, which symptoms are present, when increased in size and to exclude malignancy.

REFERENCES

1. Etemadi A, et al. Cavernous hemangioma of the liver: factors affecting disease progression in general hepatology practice. Eur J Gastroenterol Hepatol 2011; 23(4): 354-8.

2. Ehrl D, et al. Incidentaloma of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012; 2012; 891787.

3. Glinkova V, et al. Hepatic haemangiomas: possible association with female sex hormones. Gut 2004; 53(9): 1352-5.

4. Erdogan D, et al. Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol 2007; 22(11): 1953-8.

5. Yoon SS, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003; 197(3): 392-402.

6. Yedibela S, et al. Management of Hemangioma of the Liver: Surgical Therapy or Observation? World J Surg 2013.

7. Yamashita S, et al. Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol 2013; 6(1): 55-62.